+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Eisai Co - logo

Eisai Limited is a research-based pharmaceutical company that develops, manufactures, and markets healthcare products for patients and their families. It offers products in the areas of Alzheimer's disease, gastrointestinal disorders, epilepsy, cervical dystonia, severe chronic pain, and oncology. The company was founded in 1988 and is based in Hatfield, United Kingdom. It also has operations in the United States, Asia, and Europe.

Gallbladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Gallbladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 195 Pages
  • Global
From
Overactive Bladder Treatment Market - Global Forecast 2025-2032 - Product Thumbnail Image

Overactive Bladder Treatment Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 197 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2025

  • Report
  • October 2025
  • 500 Pages +
  • Global
From
Peripheral T-Cell Lymphoma Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Peripheral T-Cell Lymphoma Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • February 2024
  • 228 Pages
  • Global
From
Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics Market Report 2025 - Product Thumbnail Image

Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Pruritus Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pruritus Therapeutics - Global Strategic Business Report

  • Report
  • November 2025
  • 192 Pages
  • Global
From
B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2025 - Product Thumbnail Image

B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 925 Pages
  • Global
From
Follicular Lymphoma - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Follicular Lymphoma - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Ureter Cancer Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Ureter Cancer Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • September 2024
  • 80 Pages
  • Global
From
Alzheimer's Disease: 68-Market Analysis and Sales Forecast - Update - Product Thumbnail Image

Alzheimer's Disease: 68-Market Analysis and Sales Forecast - Update

  • Report
  • August 2025
  • 19 Pages
  • Global
From
Alzheimer's Disease: Eight-Market Drug Forecast and Market Analysis - Update - Product Thumbnail Image

Alzheimer's Disease: Eight-Market Drug Forecast and Market Analysis - Update

  • Report
  • August 2025
  • 160 Pages
  • Global
From
Rare Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Rare Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • January 2024
  • 283 Pages
  • Global
Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020 - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 693 Pages
  • Global
From
Blood-based Biomarker for Sports Medicine - Global Strategic Business Report - Product Thumbnail Image

Blood-based Biomarker for Sports Medicine - Global Strategic Business Report

  • Report
  • November 2025
  • 191 Pages
  • Global
From
Muscle Relaxant Drugs - Global Strategic Business Report - Product Thumbnail Image

Muscle Relaxant Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 371 Pages
  • Global
From
Epilepsy Therapeutics Market Report 2024-2034 - Product Thumbnail Image

Epilepsy Therapeutics Market Report 2024-2034

  • Report
  • February 2024
  • 213 Pages
  • Global
From
Cancer Biologics Market Report 2023-2033 - Product Thumbnail Image

Cancer Biologics Market Report 2023-2033

  • Report
  • June 2023
  • 308 Pages
  • Global
From
Metastatic Ovarian Cancer Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Metastatic Ovarian Cancer Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • August 2024
  • 89 Pages
  • Global
From
Gastroesophageal Reflux Disease (GERD) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Gastroesophageal Reflux Disease (GERD) Therapeutics - Global Strategic Business Report

  • Report
  • November 2025
  • 186 Pages
  • Global
From
Loading Indicator